Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
3(14%)
Results Posted
50%(4 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_3
9
43%
Ph not_applicable
5
24%
Ph phase_2
1
5%
Ph phase_4
2
10%
Ph phase_1
3
14%

Phase Distribution

3

Early Stage

1

Mid Stage

11

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
3(15.0%)
Phase 2Efficacy & side effects
1(5.0%)
Phase 3Large-scale testing
9(45.0%)
Phase 4Post-market surveillance
2(10.0%)
N/ANon-phased studies
5(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

21

all time

Status Distribution
Active(8)
Completed(8)
Terminated(2)
Other(3)

Detailed Status

Completed8
Not yet recruiting5
Recruiting3
unknown3
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
3
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (15.0%)
Phase 21 (5.0%)
Phase 39 (45.0%)
Phase 42 (10.0%)
N/A5 (25.0%)

Trials by Status

withdrawn15%
recruiting314%
not_yet_recruiting524%
unknown314%
completed838%
terminated15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07454772Phase 1

Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis

Not Yet Recruiting
NCT03384277Phase 4

Trial of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab

Completed
NCT07075315Phase 3

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial

Not Yet Recruiting
NCT06855667Not Applicable

Efficacy and Safety of Therapeutic Plasma Exchange vs Standard Medical Therapy in Severe Autoimmune Hepatitis.

Not Yet Recruiting
NCT03030417Phase 1

Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas

Completed
NCT03801512Not Applicable

Comparing the Efficacy of Steroid, Acupuncture and Platelet Rich Plasma Injection in Patients with Sciatica

Recruiting
NCT06467526Phase 2

Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss

Not Yet Recruiting
NCT05917340Phase 3

Intensified Short Course Regimen for TBM in Adults

Not Yet Recruiting
NCT06079788Phase 3

Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized,Open-label Clinical Trial.

Recruiting
NCT05734794Phase 3

Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial

Recruiting
NCT05933291

Single-cell Landscape of BALF in Patients With Severe ARDS and CARDS

Completed
NCT05818111Not Applicable

Comparison of Different Volume of Steroid Hydrodilatation in Treating Patients With Adhesive Capsulitis

Unknown
NCT05423496Not Applicable

KidneyCare Immuno-optimization in Renal Allografts (KIRA)

Withdrawn
NCT04775225Phase 3

Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis

Completed
NCT05504759Not Applicable

Efficacy of Dry Needling in the Treatment of Lateral Epicondylitis

Unknown
NCT02442180Phase 3

Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid

Terminated
NCT02286960Phase 4

Investigation of the Role of Steroids in Enhancing Voice Therapy Outcomes

Completed
NCT00154284Phase 3

Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients

Completed
NCT00867607Phase 1

Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis

Completed
NCT02351427Phase 3

Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
21